Greenland Mines Ltd quarterly report, Q2 FY2023

Filing summary

Entity discrepancy: The request identifies Greenland Mines Ltd, but the supplied Form 10-Q is for Redwoods Acquisition Corp. This summary reflects the filing provided, not Greenland Mines Ltd.

Business context and reporting period

Quarter ended June 30, 2023; filed August 21, 2023. Redwoods was a shell company seeking a business combination and had no operating revenue or commenced operations. It signed a business combination agreement with ANEW Medical, Inc. on May 30, 2023, based on an implied ANEW equity value of $60 million. The proposed transaction would make ANEW a wholly owned subsidiary and rename the company ANEW Medical, Inc.; completion remained subject to conditions and approvals.

Financial results and liquidity

  • Revenue: None. The company’s income was non-operating, principally interest earned on trust investments.
  • Quarterly result: Net loss of $153,546 for Q2 2023, compared with a $208,826 loss in Q2 2022. Q2 2023 included $862,224 of trust interest, $324,051 of general and administrative expense, $173,949 of income tax expense, and fair-value losses on convertible notes and warrants.
  • Six-month result: Net income of $967,065 for the six months ended June 30, 2023, versus a $213,836 loss in 2022. Trust interest was $2,112,292; income tax expense was $429,722.
  • Cash flow: Operating activities used $886,472 in the first half of 2023, versus $386,623 used in the prior-year period. Cash at quarter-end was $123,722.
  • Assets and trust: Total assets were $57.21 million, including $56.95 million held in the trust account. Trust assets were down from $117.81 million at December 31, 2022, primarily following public-share redemptions.
  • Liquidity and liabilities: Working capital deficit was $646,300, excluding income and franchise taxes payable that management expected to pay from the trust. Total liabilities were $6.73 million, including $870,000 of sponsor notes and $4.31 million of deferred underwriting fees payable upon a completed business combination.
  • Margins: Not meaningful because the company had no operating revenue.

Material changes, outlook, and risks

  • At the March 2023 extension vote, holders redeemed 6,103,350 public shares for approximately $63.17 million. The sponsor deposited $360,000 into the trust on June 29, extending the business-combination deadline to October 4, 2023; further monthly extensions, subject to stated terms, could extend it to December 4, 2023.
  • The ANEW agreement provides for $60 million of equity consideration and up to 5 million contingent shares tied to specified post-closing share-price targets. A separate 1.375 million founder-share tranche is also subject to performance-based release conditions.
  • Management said substantial doubt existed about the company’s ability to continue as a going concern because of limited outside-trust liquidity and the approaching deadline. If no combination were completed within the permitted period, the company would be required to liquidate.
  • The company recorded a $631,696 excise-tax liability related to 2023 redemptions under the Inflation Reduction Act. The tax, transaction costs, further redemptions, and need for additional financing could reduce funds available for a transaction.
  • The filing cites inflation, rising interest rates, financial-market instability, COVID-19 effects, and geopolitical events as risks whose specific impact was not determinable. No legal proceedings were reported. Management stated disclosure controls were effective and reported no material change in internal control over financial reporting.

Important facts for investors to verify

  • Confirm that Redwoods Acquisition Corp.—not Greenland Mines Ltd—is the intended filing and issuer.
  • Check the subsequent status and terms of the proposed ANEW transaction, including approvals, financing, redemptions, and closing conditions.
  • Verify the business-combination deadline and any extensions; the dates stated above are those disclosed in this 2023 filing.
  • Review the sponsor notes, deferred underwriting fee, excise-tax liability, and the company’s limited cash outside the trust account.
  • Assess the dilution implications of contingent consideration shares, deferred founder shares, rights, warrants, and any transaction financing.